A new CDC analysis reveals that gestational diabetes has become a big problem over the last 30 years, especially as Americans became more sedentary during the COVID-19 pandemic. Longer-term trends, such as the climbing age of women giving birth and the shifting ethnic demographics of mothers, have also contributed to the growing prevalence of gestational diabetes, which can cause problems during delivery and create ongoing health complications for babies.

FDA has received reports of hundreds of thousands of serious adverse events associated with fluoroquinolones from more than 60,000 patients since the 1980s. The most frequent adverse effects include tendon rupture and neurological and psychiatric symptoms. However, experts estimate that only a small fraction of such events are reported to FDA.

On Monday, FDA issued a proposed rule aimed at expanding the range of marketed nonprescription drugs available to consumers. The Nonprescription Drug Product with an Additional Condition for Nonprescription Use rule seeks to empower consumers to self-treat certain common conditions and improve public health.